Search Results - "Stenfert Kroese, M. C."

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy by Wortman, B. G., Creutzberg, C. L., Putter, H., Jürgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., van der Steen-Banasik, E. M., Mens, J. W. M., Slot, A., Kroese, M. C. Stenfert, van Triest, B., Nijman, H. W., Stelloo, E., Bosse, T., de Boer, S. M., van Putten, W. L. J., Smit, V. T. H. B. M, Nout, R. A.

“…Background PORTEC-2 was a randomised trial for women with high-intermediate risk (HIR) endometrial cancer, comparing pelvic external beam radiotherapy (EBRT)…”
Get full text

Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial by Raphael Daniela, D. B., Russell, N. S., van Werkhoven, E., Immink, J. M., Westhoff, D. P. G., Stenfert Kroese, M. C., Stam, M. R., van Maurik, L. M., van Gestel, C. M. J., van der Weijden, T., Boersma, L. J.

“…Purpose Patient decision aids (PtDAs) have been reported to have a positive influence on patients making a health care decision in trials. Nevertheless,…”
Get full text

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial by Nout, RA, Dr, Smit, VTHBM, MD, Putter, H, PhD, Jürgenliemk-Schulz, IM, MD, Jobsen, JJ, MD, Lutgens, LCHW, MD, van der Steen-Banasik, EM, MD, Mens, JWM, MD, Slot, A, MD, Kroese, MC Stenfert, MD, van Bunningen, BNFM, MD, Ansink, AC, MD, van Putten, WLJ, MSc, Creutzberg, CL, MD

“…Summary Background After surgery for intermediate-risk endometrial carcinoma, the vagina is the most frequent site of recurrence. This study established…”
Get full text

Risk communication in a patient decision aid for radiotherapy in breast cancer: How to deal with uncertainty? by Raphael, D.B., Russell, N.S., Immink, J.M., Westhoff, P.G., Stenfert Kroese, M.C., Stam, M.R., van Maurik, L.M., van den Bongard, H.J.G.D., Maduro, J.H., Sattler, M.G.A., van der Weijden, T., Boersma, L.J.

“…Patient decision aids for oncological treatment options, provide information on the effect on recurrence rates and/or survival benefit, and on side-effects…”
Get full text

A patient decision aid for breast cancer patients deciding on their radiation treatment, no change in decisional conflict but better informed choices by Raphael, D.B., Russell, N.S., Winkens, B., Immink, J.M., Westhoff, P.G., Stenfert Kroese, M.C., Stam, M.R., Bijker, N., van Gestel, C.M.J., van der Weijden, T., Boersma, L.J.

“…•No difference was found in decisional conflict with or without PtDA use.•Patients who used the PtDA had more knowledge, suggesting a better informed…”
Get full text

Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer by Horeweg, Nanda, Nout, Remi A, Jürgenliemk-Schulz, Ina M, Lutgens, Ludy C H W, Jobsen, Jan J, Haverkort, Marie A D, Mens, Jan Willem M, Slot, Annerie, Wortman, Bastiaan G, de Boer, Stephanie M, Stelloo, Ellen, Verhoeven-Adema, Karen W, Putter, Hein, Smit, Vincent T H B M, Bosse, Tjalling, Creutzberg, Carien L

“…The molecular classification of endometrial cancer (EC) has proven to have prognostic value and is predictive of response to adjuvant chemotherapy. Here, we…”
Get full text

Ultrasonically guided transperineal seed implantation of the prostate: modification of the technique and qualitative assessment of implants by van't Riet, A, te Loo, H J, Ypma, A F, Mak, A C, van Slooten, F H, Hoekstra, C J, Stenfert Kroese, M C

“…During the period 1988-1991, 23 patients with prostatic carcinoma were treated by transperineal iodine seed implantation guided by transrectal ultrasound. We…”
Get more information

Evaluation of brachytherapy implants using the "natural" volume-dose histogram by van 't Riet, A, te Loo, H J, Mak, A C, Veen, R E, Ypma, A F, Bos, J, Hoekstra, C J, Stenfert Kroese, M C

“…The "natural" volume-dose histogram as described by Anderson visualises graphically even small differences between source arrangements, making it a useful tool…”
Get more information

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomisedtrial by NOUT, R. A, SMIT, V. T.h B. M, VAN BUNNINGEN, B. N.f M, ANSINK, A. C, VAN PUTTEN, W. L. J, CREUTZBERG, C. L, PUTTER, H, JÜRGENLIEMK-SCHULZ, I. M, JOBSEN, J. J, LUTGENS, L. C.h W, VAN DER STEEN-BANASIK, E. M, MENS, J. W. M, SLOT, A, STENFERT KROESE, M. C

Get full text

Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial by de Boer, Stephanie M., MD, Nout, Remi A., MD, PhD, Jürgenliemk-Schulz, Ina M., MD, PhD, Jobsen, Jan J., MD, PhD, Lutgens, Ludy C.H.W., MD, PhD, van der Steen-Banasik, Elzbieta M., MD, Mens, Jan Willem M., MD, Slot, Annerie, MD, Stenfert Kroese, Marika C., MD, Oerlemans, Simone, PhD, Putter, Hein, MD, PhD, Verhoeven-Adema, Karen W., PhD, Nijman, Hans W., MD, PhD, Creutzberg, Carien L., MD, PhD

“…Purpose To evaluate the long-term health-related quality of life (HRQL) after external beam radiation therapy (EBRT) or vaginal brachytherapy (VBT) among…”
Get full text

Cutaneous metastases of endometrial adenocarcinoma with squamous cell differentiation by Dekker, Karin S, van der Linden, Paul J.Q, Stenfert Kroese, Marika C, Hofstee, Nikolaas

Get full text

Breast preserving therapy: shorter treatment duration by the peroperative introduction of iridium guide needles by Heeres, P H, Mak, A C, te Loo, H J, van Slooten, F H, Stenfert Kroese, M C, van 't Riet, A

“…In the Deventer Radiotherapeutic Institute from January 1981 through December 1989, 359 patients who had undergone a breast-saving operation were irradiated…”
Get more information